Study Group: Mammosite Users: Oncologists (US)(?)
Council Members in this Study Group: 25
Request a survey with this Study Group
Leading Experts in this Study Group
Charles Bennett, M.D.Radiation Oncologist
Robert Boissoneault Oncology Institute
Charles Bennett, MD, is a board certified Radiation Oncologist at the Robert Boissoneault Oncology Institute, Florida. He specializes in breast, prostate and metastatic cancer treatment with radiopharmaceauticals. Dr. Bennett has participated in several national forums dealing with radiopharmaceautical...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Tomotherapy may do well after all with newer bells and whistles introduced at ASTRO 2008. Protons are likely to die leaving investors with a huge bill and dwindling ROI. Short course breast radiotherapy is not worth the risk.
SenoRx has released the Contura system which provides a superior system when compared to the Mammosite Breast Brachytherapy System. These advantages include: 1. Better dosimetry, opening the door for more patients to be treated by avoiding the elimination of some patients due to skin spacing...
This article reports on Varian's answer to Tomotherapy which has been gaining some market share in the Radiation Oncology linear accelerator arena. Tomotherapy has a good product but requires a shift in treatment planning technique and complete replacement of hardware. There have been reports about...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Partner
- Physician - Department Chair
- President
- Owner
- Medical Director
- Dean / Emeritus / Senior Fellow